Effect of diclofenac etalhyaluronate (SI-613) on the production of high molecular weight sodium hyaluronate in human synoviocytes

被引：0
|
作者：
Tomochika Kisukeda
Junichi Onaya
Keiji Yoshioka
机构：
[1] Seikagaku Corporation,Central Research Laboratories, Research & Development Division
来源：
BMC Musculoskeletal Disorders | / 20卷
关键词：
Osteoarthritis; Hyaluronan; Diclofenac etalhyaluronate; Hyaluronan synthase; Hyaluronidase;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Effect of diclofenac etalhyaluronate (SI-613) on the production of high molecular weight sodium hyaluronate in human synoviocytes
    Kisukeda, Tomochika
    Onaya, Junichi
    Yoshioka, Keiji
    BMC MUSCULOSKELETAL DISORDERS, 2019, 20 (1)
  • [2] Open-label phase 3 study of diclofenac conjugated to hyaluronate (diclofenac etalhyaluronate: ONO-5704/SI-613) for treatment of osteoarthritis: 1-year follow-up
    Nishida, Yoshihiro
    Kano, Kazuyuki
    Osato, Taiki
    Seo, Takayuki
    BMC MUSCULOSKELETAL DISORDERS, 2021, 22 (01)
  • [3] Open-label phase 3 study of diclofenac conjugated to hyaluronate (diclofenac etalhyaluronate: ONO-5704/SI-613) for treatment of osteoarthritis: 1-year follow-up
    Yoshihiro Nishida
    Kazuyuki Kano
    Taiki Osato
    Takayuki Seo
    BMC Musculoskeletal Disorders, 22
  • [4] Effects of Diclofenac Etalhyaluronate (SI-613/ONO-5704) on Cartilage Degeneration in Arthritic Rats and Inflammatory Cytokine-Stimulated Human Chondrocytes
    Takada, Shuhei
    Nodera, Risa
    Yoshioka, Keiji
    CARTILAGE, 2024,
  • [5] Pharmacological effects of N-[2-[[2-[2-[(2,6-dichlorophenyl)amino]phenyl]acetyl]oxy]ethyl]hyaluronamide (diclofenac Etalhyaluronate, SI-613), a novel sodium hyaluronate derivative chemically linked with diclofenac
    Yoshioka, Keiji
    Kisukeda, Tomochika
    Zuinen, Ryoji
    Yasuda, Yosuke
    Miyamoto, Kenji
    BMC MUSCULOSKELETAL DISORDERS, 2018, 19
  • [6] Pharmacological effects of N-[2-[[2-[2-[(2,6-dichlorophenyl)amino]phenyl]acetyl]oxy]ethyl]hyaluronamide (diclofenac Etalhyaluronate, SI-613), a novel sodium hyaluronate derivative chemically linked with diclofenac
    Keiji Yoshioka
    Tomochika Kisukeda
    Ryoji Zuinen
    Yosuke Yasuda
    Kenji Miyamoto
    BMC Musculoskeletal Disorders, 19
  • [7] EFFECT OF HIGH-MOLECULAR-WEIGHT SODIUM HYALURONATE ON IMMOBILIZED RABBIT KNEE
    SAKAKIBARA, Y
    MIURA, T
    IWATA, H
    KIKUCHI, T
    YAMAGUCHI, T
    YOSHIMI, T
    ITOH, H
    CLINICAL ORTHOPAEDICS AND RELATED RESEARCH, 1994, (299) : 282 - 292
  • [8] EFFECT OF THE CATIONS SODIUM AND POTASSIUM ON THE MOLECULAR-WEIGHT OF HYALURONATE
    MANSSON, P
    JACOBSSON, O
    GRANATH, KA
    INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 1985, 7 (01) : 30 - 32
  • [9] Desirable effect of combination therapy with high molecular weight hyaluronate and NSAIDs on MMP production
    Hashizume, M.
    Mihara, M.
    OSTEOARTHRITIS AND CARTILAGE, 2009, 17 (11) : 1513 - 1518
  • [10] THE INFLUENCE OF HIGH MOLECULAR-WEIGHT SODIUM HYALURONATE (HEALON) ON THE PRODUCTION OF MIGRATION-INHIBITORY FACTOR
    VANDERGAAG, R
    BROERSMA, L
    KOORNNEEF, L
    CURRENT EYE RESEARCH, 1987, 6 (12) : 1433 - 1440
12345